Skip to main content
Midas Edge

Scienture Holdings, Inc.

For the period ended Dec 31, 2025. Filed Mar 30, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 30, 2026

SCNX$3.04-5.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

Consolidated Statements of Changes in Stockholders’ Equity

Series A · Series B · Series C · Series X · Common · Additional · Total
Preferred Stock · Preferred Stock · Preferred Stock · Preferred Stock · Stock · Paid-in · Accumulated · Stockholders’
Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Shares · Amount · Capital · Deficit · Equity
Balances at December 31, 2023-$-15,759$-290$--$-905,008$9$33,788,284$(33,245,940)$542,353
Common stock issued for services--------490,69854,598,289-4,598,294
Conversion of Series C preferred stock into common stock----(290)---52,1581(1)--
Issuance of shares pursuant to Merger------6,826,75368291,536378,646,113-78,646,184
Conversion of Series X preferred stock into common stock------(6,826,753)(68)6,826,75368---
Equity line of commitment shares issued--------70,0001534,799-534,800
Issuance of common shares in connection with convertible note--------55,0001420,199-420,200
Warrants issued with convertible note----------71,332-71,332
Options exercised for common shares--------2,371-9,840-9,840
Warrants exercised for cash--------57,058-16,567-16,567
Options expense----------25,584-25,584
Cash dividends paid ($8 per share)-----------(12,671,072)(12,671,072)
Cash dividends paid ($1.50 per share)-----------(2,187,759)(2,187,759)
Net income-----------9,065,7989,065,798
Balances at December 31, 2024--15,759-----8,750,58287118,111,007(39,038,973)79,072,121
Common stock issued for services--------3,760,150384,310,052-4,310,090
Common stock issued for cash, net of offering costs--------22,826,27322823,879,077-23,879,305
Cancellation of stock options and issuance of common stock--------2,000,000201,512,974-1,512,994
Equity line of commitment shares issued--------1,064,512111,526,307-1,526,318
Conversion of note payable into common stock--------274,0003410,997-411,000
Common stock issued for convertible note settlement--------224,9982189,671-189,673
Common stock issued for convertible note extension--------250,0003175,248-175,250
Warrants exercised for shares--------279,4023(3)--
Restricted shares issued for services--------1,200,89812(12)--
Stock-based compensation expense----------555,898-555,898
Net loss-----------(41,512,264)(41,512,264)
Balances at December 31, 2025-$-15,759$--$--$-40,630,815$406$150,671,215$(80,551,237)$70,120,384
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.